Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1996 | 2 |
2002 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
The alpha-glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoprotein-mediated membrane fusion at the CXCR4 binding step.
Mol Pharmacol. 2002 Jan;61(1):186-93. doi: 10.1124/mol.61.1.186.
Mol Pharmacol. 2002.
PMID: 11752220
N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure.
Fischer PB, Karlsson GB, Dwek RA, Platt FM.
Fischer PB, et al.
J Virol. 1996 Oct;70(10):7153-60. doi: 10.1128/JVI.70.10.7153-7160.1996.
J Virol. 1996.
PMID: 8794362
Free PMC article.
Item in Clipboard
N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.
Fischer PB, Karlsson GB, Butters TD, Dwek RA, Platt FM.
Fischer PB, et al.
J Virol. 1996 Oct;70(10):7143-52. doi: 10.1128/JVI.70.10.7143-7152.1996.
J Virol. 1996.
PMID: 8794361
Free PMC article.
Item in Clipboard
Cite
Cite